Get started
Author

Sarah Schellhorn Mougalian

Observed names: Mougalian, Sarah, Mougalian, Sarah S., S Mougalian, S. Mougalian, S.S. Mougalian, SS Mougalian, Sarah E Schellhorn, Sarah Mougalian, Sarah S Mougalian, Sarah S. Mougalian, Sarah Schellhorn
Observed institutions: American Cancer Society, Yale New Haven Hospital, Mayo Clinic, The University of Texas MD Anderson Cancer Center, University of Wisconsin–Madison, Thomas Jefferson University, Yale Cancer Center, Yale University, Sidney Kimmel Cancer Center, Dana-Farber Cancer Institute, National Institute of Oncology, Optum (United States), Cardinal Health (United States), Eisai (United States), UC Davis Health, Smilow Cancer Hospital, The Ohio State University
ORCID: 0000-0002-8837-1425
Observed ORCID: 0000-0002-8837-1425
OpenAlex ID: A5109390868
Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States
2015 · Sarah S. Mougalian, Pamela R. Soulos, et al. · Cancer · 237
PDF
Neoadjuvant Chemotherapy for Breast Cancer Increases the Rate of Breast Conservation: Results from the National Cancer Database
2015 · Brigid K. Killelea, Vicky Q. Yang, et al. · Journal of the American College of Surgeons · 197
Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy
2015 · Sarah S. Mougalian, Mike Hernandez, et al. · JAMA Oncology · 164
PDF
Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base
2015 · Brigid K. Killelea, Vicky Q. Yang, et al. · Journal of Clinical Oncology · 108
Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal
2018 · Shi-Yi Wang, Weixiong Dang, et al. · Journal of Clinical Oncology · 88
Adoption of Hypofractionated Whole-Breast Irradiation for Early-Stage Breast Cancer: A National Cancer Data Base Analysis
2014 · Elyn H. Wang, Sarah S. Mougalian, et al. · International Journal of Radiation Oncology*Biology*Physics · 80
Cognitive Effects and Depression Associated With Taxane-Based Chemotherapy in Breast Cancer Survivors: A Meta-Analysis
2021 · Eiman Y. Ibrahim, Ilaria Domenicano, et al. · Frontiers in Oncology · 63
PDF
Information Needs of Older Women With Early-Stage Breast Cancer When Making Radiation Therapy Decisions
2017 · Shi-Yi Wang, Gabrielle Kelly, et al. · International Journal of Radiation Oncology*Biology*Physics · 50
PDF
Patient preferences regarding incidental genomic findings discovered during tumor profiling
2016 · Melinda L. Yushak, Gang Han, et al. · Cancer · 49
PDF
Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy
2021 · Mariya Rozenblit, Sophia Mun, et al. · Breast Cancer Research · 45
PDF
Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ
2018 · Brigid K. Killelea, Jessica B. Long, et al. · Annals of Surgical Oncology · 45
PDF
Association of LN Evaluation with Survival in Women Aged 70 Years or Older With Clinically Node-Negative Hormone Receptor Positive Breast Cancer
2017 · Anees B. Chagpar, Christos Hatzis, et al. · Annals of Surgical Oncology · 41
Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer
2015 · Tara Sanft, Bilge Aktas, et al. · Breast Cancer Research and Treatment · 39
PDF
Bidirectional Text Messaging to Monitor Endocrine Therapy Adherence and Patient-Reported Outcomes in Breast Cancer
2017 · Sarah S. Mougalian, Lianne N. Epstein, et al. · JCO Clinical Cancer Informatics · 37
Prediction model for mortality after intracranial hemorrhage in patients with leukemia
2011 · Farshid Dayyani, Sarah Schellhorn Mougalian, et al. · American Journal of Hematology · 36
The impact of communication style on patient satisfaction
2019 · Amelia A. Trant, Borbala Szekely, et al. · Breast Cancer Research and Treatment · 35
Incorporating Tumor Characteristics to Maximize 21-Gene Assay Utility: A Cost-Effectiveness Analysis
2019 · Shi-Yi Wang, Tiange Chen, et al. · Journal of the National Comprehensive Cancer Network · 31
PDF
Association between prolonged metastatic free interval and recurrent metastatic breast cancer survival: findings from the SEER database
2018 · Enoch Chang, Sarah S. Mougalian, et al. · Breast Cancer Research and Treatment · 29
Palliative care training and associations with burnout in oncology fellows
2013 · Sarah Mougalian, David Lessen, et al. · The Journal of Supportive Oncology · 29
PDF
Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors
2018 · Kathryn J. Ruddy, Lindsey Sangaralingham, et al. · Journal of the National Comprehensive Cancer Network · 27
PDF
Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women WithERBB2(HER2)–Positive Breast Cancer
2020 · Natalia Kunst, Shi-Yi Wang, et al. · JAMA Network Open · 25
PDF
Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States
2019 · Ashley C. Pariser, Tannaz Sedghi, et al. · Breast Cancer Research and Treatment · 25
Adoption of Intensity Modulated Radiation Therapy For Early-Stage Breast Cancer From 2004 Through 2011
2014 · Elyn H. Wang, Sarah S. Mougalian, et al. · International Journal of Radiation Oncology*Biology*Physics · 24
Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States
2021 · Sarah S. Mougalian, Jonathan K. Kish, et al. · Advances in Therapy · 23
PDF
Text Messaging in Oncology: A Review of the Landscape
2018 · Sarah S. Mougalian, Cary P. Gross, et al. · JCO Clinical Cancer Informatics · 23
Works count: 120
Citation count: 1,911
H-index: 23
I10-index: 41
Year
Topic
Type